<DOC>
	<DOCNO>NCT02652988</DOCNO>
	<brief_summary>In phase II , randomize , double-blind clinical trial , investigator intend evaluate home-based effect transcranial direct current stimulation ( tDCS ) patient fibromyalgia . This syndrome affect 3-5 % population age group 40-60 year also occur childhood old age . Reaches 3.4 % woman 0.5 % men . Fibromyalgia chronic widespread pain syndrome various part body . The neuromodulation technique principle produce inhibition cortical arousal . The tDCS non-invasive brain stimulation method use modulate cortical excitability , use low intensity direct current ( 1-2mA ) direct scalp via cathode anode electrode . The current reach cortex , produce hyperpolarization depolarization axonal membrane potential . Evidence show method present technique able alter cortical subcortical neural network . This technique use treat psychiatric disorder depression , acute mania , bipolar affective disorder , panic , hallucination , obsessive compulsive disorder , schizophrenia , withdrawal , rehabilitation stroke , pain syndrome neuropathic pain , migraine , pancreatitis pain chronic fibromyalgia . The tDCS low cost technique , virtually side effect exert therapeutic effect neuromodulatory pathway distinct pathway activate drug . In scenario fall within importance develop device home use fibromyalgia patient , since easy use thereby enables maintain benefit observed study perform supervise frequently use care center . The use tDCS long term feasible hospital patient demand , sometimes every day week , remove patient activity , cost shift overload healthcare system . Therefore , objective study evaluate effect home-based tDCS fibromyalgia patient long-term treatment .</brief_summary>
	<brief_title>Home-based Transcranial Direct Current Stimulation Fibromyalgia Patients</brief_title>
	<detailed_description>Will include woman age 18 65 year , chronic pain fibromyalgia accord criterion American College Rheumatology , pain unresponsive analgesic paracetamol , acetylsalicylic acid , ibuprofen , Carisoprodol , Zanaflex ( Tizanidine ) Codeine . And give informed consent participate initial evaluation . Primary outcome evaluate effect treatment home-base tDCS patient fibromyalgia . Secondary outcome : compare effect active home-based tDCS sham cortical neurophysiological process subcortical stimulation TMS standardize noxious stimulus without concomitant condition Pain Modulation ( CPM ) pain threshold outcomes test mechanical pressure , heat-algesic stimulus , cortical excitability parameter [ evoke rest motor ( MEP ) MEP enough evoke amplitude 1 mV peak peak , silent period ( SP ) , motor threshold ( MT ) , variation blood volume oxygenation cortical motor area [ oxy-hemoglobin concentration ( Hbo ) / deoxy-hemoglobin ( HBr ) ] optically functional neuroimaging ( NIRS ) variation frequency alpha beta wave motor area stimulate tDCS assess electroencephalogram ( EEG ) . In surrogate outcome , investigator compare effect active home-sham tDCS tDCS pain level functional capacity , catastrophic thinking , bookmark level neurotrophic activity ( BDNF ) astrocytic ( S100 beta ) .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>chronic pain fibromyalgia accord criterion American College Rheumatology Pain unresponsive analgesic paracetamol , acetyl salicylic acid , Ibuprofen , Carisoprodol , Zanaflex ( Tizanidine ) Codeine Give inform consent participate initial evaluation . Pregnancy Treatment carbamazepine gabapentin The . Metallic implant brain Medical device implant brain Alcohol drug abuse history last 6 month Suffering severe depression ( score &gt; 30 Beck Depression Inventory ) History neurological disorder Unexplained faint History History head trauma momentary loss consciousness ( self report ) Neurosurgery History Decompensated systemic disease , chronic inflammatory disease ( lupus , rheumatoid arthritis , renal failure hepatitis ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tDCS</keyword>
	<keyword>chronic pain</keyword>
	<keyword>fibromyalgia</keyword>
</DOC>